nodes	percent_of_prediction	percent_of_DWPC	metapath
Histamine Phosphate—SLC22A3—Progesterone—uterine cancer	0.216	0.285	CbGbCtD
Histamine Phosphate—SLC22A2—Progesterone—uterine cancer	0.128	0.169	CbGbCtD
Histamine Phosphate—SLC22A1—Progesterone—uterine cancer	0.111	0.147	CbGbCtD
Histamine Phosphate—SLC22A5—Dactinomycin—uterine cancer	0.106	0.14	CbGbCtD
Histamine Phosphate—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0529	0.0699	CbGbCtD
Histamine Phosphate—CYP2C9—Progesterone—uterine cancer	0.0351	0.0463	CbGbCtD
Histamine Phosphate—CYP2D6—Progesterone—uterine cancer	0.0321	0.0423	CbGbCtD
Histamine Phosphate—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0308	0.0406	CbGbCtD
Histamine Phosphate—CYP3A4—Progesterone—uterine cancer	0.0204	0.0269	CbGbCtD
Histamine Phosphate—CYP2D6—Doxorubicin—uterine cancer	0.00979	0.0129	CbGbCtD
Histamine Phosphate—CYP3A4—Etoposide—uterine cancer	0.00912	0.012	CbGbCtD
Histamine Phosphate—CYP3A4—Doxorubicin—uterine cancer	0.00622	0.00821	CbGbCtD
Histamine Phosphate—HNMT—epithelium—uterine cancer	0.00243	0.0538	CbGeAlD
Histamine Phosphate—HNMT—decidua—uterine cancer	0.00229	0.0509	CbGeAlD
Histamine Phosphate—HNMT—renal system—uterine cancer	0.00225	0.0499	CbGeAlD
Histamine Phosphate—HNMT—female reproductive system—uterine cancer	0.0018	0.04	CbGeAlD
Histamine Phosphate—HNMT—female gonad—uterine cancer	0.00164	0.0364	CbGeAlD
Histamine Phosphate—HNMT—vagina—uterine cancer	0.00163	0.0362	CbGeAlD
Histamine Phosphate—SLC22A2—renal system—uterine cancer	0.00159	0.0352	CbGeAlD
Histamine Phosphate—SLC22A3—myometrium—uterine cancer	0.00147	0.0327	CbGeAlD
Histamine Phosphate—SLC22A3—uterine cervix—uterine cancer	0.00115	0.0254	CbGeAlD
Histamine Phosphate—SLC22A1—renal system—uterine cancer	0.00112	0.0249	CbGeAlD
Histamine Phosphate—SLC22A3—smooth muscle tissue—uterine cancer	0.00111	0.0247	CbGeAlD
Histamine Phosphate—SLC22A3—renal system—uterine cancer	0.00107	0.0238	CbGeAlD
Histamine Phosphate—SLC22A5—myometrium—uterine cancer	0.00107	0.0237	CbGeAlD
Histamine Phosphate—HNMT—lymph node—uterine cancer	0.00106	0.0234	CbGeAlD
Histamine Phosphate—SLC22A3—endometrium—uterine cancer	0.00104	0.023	CbGeAlD
Histamine Phosphate—SLC22A3—mammalian vulva—uterine cancer	0.001	0.0222	CbGeAlD
Histamine Phosphate—CA4—renal system—uterine cancer	0.000956	0.0212	CbGeAlD
Histamine Phosphate—HRH1—myometrium—uterine cancer	0.000908	0.0201	CbGeAlD
Histamine Phosphate—SLC22A3—female reproductive system—uterine cancer	0.000859	0.019	CbGeAlD
Histamine Phosphate—SLC22A5—uterine cervix—uterine cancer	0.000834	0.0185	CbGeAlD
Histamine Phosphate—HRH2—lymph node—uterine cancer	0.000816	0.0181	CbGeAlD
Histamine Phosphate—SLC22A1—vagina—uterine cancer	0.000813	0.018	CbGeAlD
Histamine Phosphate—SLC22A3—female gonad—uterine cancer	0.000782	0.0173	CbGeAlD
Histamine Phosphate—SLC22A5—renal system—uterine cancer	0.00078	0.0173	CbGeAlD
Histamine Phosphate—SLC22A3—vagina—uterine cancer	0.000777	0.0172	CbGeAlD
Histamine Phosphate—CA4—female reproductive system—uterine cancer	0.000766	0.017	CbGeAlD
Histamine Phosphate—SLC22A5—endometrium—uterine cancer	0.000754	0.0167	CbGeAlD
Histamine Phosphate—HRH1—epithelium—uterine cancer	0.000713	0.0158	CbGeAlD
Histamine Phosphate—HRH1—uterine cervix—uterine cancer	0.000707	0.0157	CbGeAlD
Histamine Phosphate—CA4—female gonad—uterine cancer	0.000697	0.0154	CbGeAlD
Histamine Phosphate—HRH1—smooth muscle tissue—uterine cancer	0.000687	0.0152	CbGeAlD
Histamine Phosphate—HRH1—decidua—uterine cancer	0.000674	0.0149	CbGeAlD
Histamine Phosphate—HRH1—endometrium—uterine cancer	0.000639	0.0142	CbGeAlD
Histamine Phosphate—SLC22A5—female reproductive system—uterine cancer	0.000625	0.0138	CbGeAlD
Histamine Phosphate—HRH1—mammalian vulva—uterine cancer	0.000618	0.0137	CbGeAlD
Histamine Phosphate—SLC22A5—female gonad—uterine cancer	0.000568	0.0126	CbGeAlD
Histamine Phosphate—SLC22A5—vagina—uterine cancer	0.000565	0.0125	CbGeAlD
Histamine Phosphate—CYP2C9—female reproductive system—uterine cancer	0.000537	0.0119	CbGeAlD
Histamine Phosphate—HRH1—female reproductive system—uterine cancer	0.00053	0.0117	CbGeAlD
Histamine Phosphate—CYP3A4—renal system—uterine cancer	0.000511	0.0113	CbGeAlD
Histamine Phosphate—CYP2D6—renal system—uterine cancer	0.000503	0.0112	CbGeAlD
Histamine Phosphate—SLC22A3—lymph node—uterine cancer	0.000502	0.0111	CbGeAlD
Histamine Phosphate—HRH1—female gonad—uterine cancer	0.000482	0.0107	CbGeAlD
Histamine Phosphate—HRH1—vagina—uterine cancer	0.000479	0.0106	CbGeAlD
Histamine Phosphate—CA4—lymph node—uterine cancer	0.000448	0.00993	CbGeAlD
Histamine Phosphate—CYP3A4—female reproductive system—uterine cancer	0.00041	0.00908	CbGeAlD
Histamine Phosphate—CYP2D6—female reproductive system—uterine cancer	0.000403	0.00893	CbGeAlD
Histamine Phosphate—CYP2D6—female gonad—uterine cancer	0.000367	0.00813	CbGeAlD
Histamine Phosphate—SLC22A5—lymph node—uterine cancer	0.000365	0.0081	CbGeAlD
Histamine Phosphate—HRH1—lymph node—uterine cancer	0.00031	0.00687	CbGeAlD
Histamine Phosphate—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000304	0.00154	CcSEcCtD
Histamine Phosphate—Menopausal symptoms—Epirubicin—uterine cancer	0.000303	0.00153	CcSEcCtD
Histamine Phosphate—Decreased appetite—Dactinomycin—uterine cancer	0.000301	0.00152	CcSEcCtD
Histamine Phosphate—Dysgeusia—Etoposide—uterine cancer	0.0003	0.00152	CcSEcCtD
Histamine Phosphate—Renal impairment—Epirubicin—uterine cancer	0.0003	0.00152	CcSEcCtD
Histamine Phosphate—Fatigue—Dactinomycin—uterine cancer	0.000298	0.00151	CcSEcCtD
Histamine Phosphate—Back pain—Etoposide—uterine cancer	0.000297	0.0015	CcSEcCtD
Histamine Phosphate—Pain—Dactinomycin—uterine cancer	0.000296	0.0015	CcSEcCtD
Histamine Phosphate—Muscle spasms—Etoposide—uterine cancer	0.000295	0.00149	CcSEcCtD
Histamine Phosphate—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000293	0.00149	CcSEcCtD
Histamine Phosphate—Nausea—Progesterone—uterine cancer	0.000291	0.00147	CcSEcCtD
Histamine Phosphate—Renal failure acute—Doxorubicin—uterine cancer	0.000286	0.00145	CcSEcCtD
Histamine Phosphate—Pain in extremity—Epirubicin—uterine cancer	0.000286	0.00145	CcSEcCtD
Histamine Phosphate—Feeling abnormal—Dactinomycin—uterine cancer	0.000285	0.00144	CcSEcCtD
Histamine Phosphate—Ill-defined disorder—Etoposide—uterine cancer	0.000285	0.00144	CcSEcCtD
Histamine Phosphate—Anaemia—Etoposide—uterine cancer	0.000284	0.00144	CcSEcCtD
Histamine Phosphate—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000283	0.00143	CcSEcCtD
Histamine Phosphate—Hot flush—Doxorubicin—uterine cancer	0.000282	0.00143	CcSEcCtD
Histamine Phosphate—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000282	0.00143	CcSEcCtD
Histamine Phosphate—Menopausal symptoms—Doxorubicin—uterine cancer	0.00028	0.00142	CcSEcCtD
Histamine Phosphate—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00028	0.00142	CcSEcCtD
Histamine Phosphate—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000279	0.00142	CcSEcCtD
Histamine Phosphate—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000278	0.00141	CcSEcCtD
Histamine Phosphate—Renal impairment—Doxorubicin—uterine cancer	0.000278	0.00141	CcSEcCtD
Histamine Phosphate—Malaise—Etoposide—uterine cancer	0.000277	0.0014	CcSEcCtD
Histamine Phosphate—Vertigo—Etoposide—uterine cancer	0.000276	0.0014	CcSEcCtD
Histamine Phosphate—Leukopenia—Etoposide—uterine cancer	0.000275	0.00139	CcSEcCtD
Histamine Phosphate—Abdominal pain—Dactinomycin—uterine cancer	0.000274	0.00139	CcSEcCtD
Histamine Phosphate—Body temperature increased—Dactinomycin—uterine cancer	0.000274	0.00139	CcSEcCtD
Histamine Phosphate—Cardiac arrest—Epirubicin—uterine cancer	0.000272	0.00138	CcSEcCtD
Histamine Phosphate—Cough—Etoposide—uterine cancer	0.000268	0.00136	CcSEcCtD
Histamine Phosphate—Blood creatinine increased—Epirubicin—uterine cancer	0.000268	0.00136	CcSEcCtD
Histamine Phosphate—Convulsion—Etoposide—uterine cancer	0.000266	0.00135	CcSEcCtD
Histamine Phosphate—Dehydration—Epirubicin—uterine cancer	0.000266	0.00135	CcSEcCtD
Histamine Phosphate—Hypertension—Etoposide—uterine cancer	0.000265	0.00134	CcSEcCtD
Histamine Phosphate—Pain in extremity—Doxorubicin—uterine cancer	0.000264	0.00134	CcSEcCtD
Histamine Phosphate—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000263	0.00134	CcSEcCtD
Histamine Phosphate—Dry skin—Epirubicin—uterine cancer	0.000262	0.00133	CcSEcCtD
Histamine Phosphate—Chest pain—Etoposide—uterine cancer	0.000261	0.00132	CcSEcCtD
Histamine Phosphate—Abdominal pain upper—Epirubicin—uterine cancer	0.000261	0.00132	CcSEcCtD
Histamine Phosphate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000259	0.00131	CcSEcCtD
Histamine Phosphate—Discomfort—Etoposide—uterine cancer	0.000258	0.00131	CcSEcCtD
Histamine Phosphate—Hypersensitivity—Dactinomycin—uterine cancer	0.000255	0.00129	CcSEcCtD
Histamine Phosphate—Gastritis—Epirubicin—uterine cancer	0.000253	0.00128	CcSEcCtD
Histamine Phosphate—Confusional state—Etoposide—uterine cancer	0.000253	0.00128	CcSEcCtD
Histamine Phosphate—Muscular weakness—Epirubicin—uterine cancer	0.000252	0.00128	CcSEcCtD
Histamine Phosphate—Cardiac arrest—Doxorubicin—uterine cancer	0.000251	0.00127	CcSEcCtD
Histamine Phosphate—Anaphylactic shock—Etoposide—uterine cancer	0.00025	0.00127	CcSEcCtD
Histamine Phosphate—Infection—Etoposide—uterine cancer	0.000249	0.00126	CcSEcCtD
Histamine Phosphate—Abdominal distension—Epirubicin—uterine cancer	0.000249	0.00126	CcSEcCtD
Histamine Phosphate—Asthenia—Dactinomycin—uterine cancer	0.000248	0.00126	CcSEcCtD
Histamine Phosphate—Blood creatinine increased—Doxorubicin—uterine cancer	0.000248	0.00125	CcSEcCtD
Histamine Phosphate—Asthma—Epirubicin—uterine cancer	0.000247	0.00125	CcSEcCtD
Histamine Phosphate—Dysphagia—Epirubicin—uterine cancer	0.000247	0.00125	CcSEcCtD
Histamine Phosphate—Dehydration—Doxorubicin—uterine cancer	0.000246	0.00125	CcSEcCtD
Histamine Phosphate—Thrombocytopenia—Etoposide—uterine cancer	0.000245	0.00124	CcSEcCtD
Histamine Phosphate—Tachycardia—Etoposide—uterine cancer	0.000244	0.00124	CcSEcCtD
Histamine Phosphate—Eosinophilia—Epirubicin—uterine cancer	0.000244	0.00124	CcSEcCtD
Histamine Phosphate—Skin disorder—Etoposide—uterine cancer	0.000243	0.00123	CcSEcCtD
Histamine Phosphate—Dry skin—Doxorubicin—uterine cancer	0.000242	0.00123	CcSEcCtD
Histamine Phosphate—Hyperhidrosis—Etoposide—uterine cancer	0.000242	0.00123	CcSEcCtD
Histamine Phosphate—Abdominal pain upper—Doxorubicin—uterine cancer	0.000241	0.00122	CcSEcCtD
Histamine Phosphate—Anorexia—Etoposide—uterine cancer	0.000239	0.00121	CcSEcCtD
Histamine Phosphate—Diarrhoea—Dactinomycin—uterine cancer	0.000237	0.0012	CcSEcCtD
Histamine Phosphate—Hypotension—Etoposide—uterine cancer	0.000234	0.00119	CcSEcCtD
Histamine Phosphate—Gastritis—Doxorubicin—uterine cancer	0.000234	0.00119	CcSEcCtD
Histamine Phosphate—Muscular weakness—Doxorubicin—uterine cancer	0.000233	0.00118	CcSEcCtD
Histamine Phosphate—Neutropenia—Epirubicin—uterine cancer	0.000231	0.00117	CcSEcCtD
Histamine Phosphate—Abdominal distension—Doxorubicin—uterine cancer	0.00023	0.00117	CcSEcCtD
Histamine Phosphate—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000229	0.00116	CcSEcCtD
Histamine Phosphate—Dysphagia—Doxorubicin—uterine cancer	0.000228	0.00116	CcSEcCtD
Histamine Phosphate—Asthma—Doxorubicin—uterine cancer	0.000228	0.00116	CcSEcCtD
Histamine Phosphate—Eosinophilia—Doxorubicin—uterine cancer	0.000226	0.00115	CcSEcCtD
Histamine Phosphate—Paraesthesia—Etoposide—uterine cancer	0.000225	0.00114	CcSEcCtD
Histamine Phosphate—Weight increased—Epirubicin—uterine cancer	0.000225	0.00114	CcSEcCtD
Histamine Phosphate—Weight decreased—Epirubicin—uterine cancer	0.000223	0.00113	CcSEcCtD
Histamine Phosphate—Dyspnoea—Etoposide—uterine cancer	0.000223	0.00113	CcSEcCtD
Histamine Phosphate—Pneumonia—Epirubicin—uterine cancer	0.000221	0.00112	CcSEcCtD
Histamine Phosphate—Infestation—Epirubicin—uterine cancer	0.00022	0.00112	CcSEcCtD
Histamine Phosphate—Infestation NOS—Epirubicin—uterine cancer	0.00022	0.00112	CcSEcCtD
Histamine Phosphate—Vomiting—Dactinomycin—uterine cancer	0.00022	0.00111	CcSEcCtD
Histamine Phosphate—Rash—Dactinomycin—uterine cancer	0.000218	0.00111	CcSEcCtD
Histamine Phosphate—Decreased appetite—Etoposide—uterine cancer	0.000218	0.0011	CcSEcCtD
Histamine Phosphate—Renal failure—Epirubicin—uterine cancer	0.000216	0.0011	CcSEcCtD
Histamine Phosphate—Gastrointestinal disorder—Etoposide—uterine cancer	0.000216	0.0011	CcSEcCtD
Histamine Phosphate—Fatigue—Etoposide—uterine cancer	0.000216	0.00109	CcSEcCtD
Histamine Phosphate—Stomatitis—Epirubicin—uterine cancer	0.000215	0.00109	CcSEcCtD
Histamine Phosphate—Pain—Etoposide—uterine cancer	0.000214	0.00109	CcSEcCtD
Histamine Phosphate—Constipation—Etoposide—uterine cancer	0.000214	0.00109	CcSEcCtD
Histamine Phosphate—Neutropenia—Doxorubicin—uterine cancer	0.000214	0.00108	CcSEcCtD
Histamine Phosphate—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000212	0.00108	CcSEcCtD
Histamine Phosphate—Weight increased—Doxorubicin—uterine cancer	0.000208	0.00105	CcSEcCtD
Histamine Phosphate—Weight decreased—Doxorubicin—uterine cancer	0.000207	0.00105	CcSEcCtD
Histamine Phosphate—Feeling abnormal—Etoposide—uterine cancer	0.000206	0.00105	CcSEcCtD
Histamine Phosphate—Nausea—Dactinomycin—uterine cancer	0.000206	0.00104	CcSEcCtD
Histamine Phosphate—Pneumonia—Doxorubicin—uterine cancer	0.000205	0.00104	CcSEcCtD
Histamine Phosphate—Gastrointestinal pain—Etoposide—uterine cancer	0.000205	0.00104	CcSEcCtD
Histamine Phosphate—Infestation NOS—Doxorubicin—uterine cancer	0.000204	0.00103	CcSEcCtD
Histamine Phosphate—Infestation—Doxorubicin—uterine cancer	0.000204	0.00103	CcSEcCtD
Histamine Phosphate—Renal failure—Doxorubicin—uterine cancer	0.0002	0.00101	CcSEcCtD
Histamine Phosphate—Urticaria—Etoposide—uterine cancer	0.000199	0.00101	CcSEcCtD
Histamine Phosphate—Stomatitis—Doxorubicin—uterine cancer	0.000199	0.00101	CcSEcCtD
Histamine Phosphate—Abdominal pain—Etoposide—uterine cancer	0.000198	0.001	CcSEcCtD
Histamine Phosphate—Body temperature increased—Etoposide—uterine cancer	0.000198	0.001	CcSEcCtD
Histamine Phosphate—Hypoaesthesia—Epirubicin—uterine cancer	0.000197	0.000996	CcSEcCtD
Histamine Phosphate—Oedema peripheral—Epirubicin—uterine cancer	0.000195	0.000986	CcSEcCtD
Histamine Phosphate—Connective tissue disorder—Epirubicin—uterine cancer	0.000194	0.000984	CcSEcCtD
Histamine Phosphate—Hypersensitivity—Etoposide—uterine cancer	0.000185	0.000935	CcSEcCtD
Histamine Phosphate—Flushing—Epirubicin—uterine cancer	0.000183	0.000929	CcSEcCtD
Histamine Phosphate—Cardiac disorder—Epirubicin—uterine cancer	0.000183	0.000929	CcSEcCtD
Histamine Phosphate—Hypoaesthesia—Doxorubicin—uterine cancer	0.000182	0.000922	CcSEcCtD
Histamine Phosphate—Oedema peripheral—Doxorubicin—uterine cancer	0.00018	0.000913	CcSEcCtD
Histamine Phosphate—Asthenia—Etoposide—uterine cancer	0.00018	0.00091	CcSEcCtD
Histamine Phosphate—Connective tissue disorder—Doxorubicin—uterine cancer	0.00018	0.00091	CcSEcCtD
Histamine Phosphate—Angiopathy—Epirubicin—uterine cancer	0.000179	0.000908	CcSEcCtD
Histamine Phosphate—Mediastinal disorder—Epirubicin—uterine cancer	0.000178	0.000902	CcSEcCtD
Histamine Phosphate—Chills—Epirubicin—uterine cancer	0.000177	0.000898	CcSEcCtD
Histamine Phosphate—Pruritus—Etoposide—uterine cancer	0.000177	0.000898	CcSEcCtD
Histamine Phosphate—Arrhythmia—Epirubicin—uterine cancer	0.000177	0.000894	CcSEcCtD
Histamine Phosphate—Mental disorder—Epirubicin—uterine cancer	0.000173	0.000877	CcSEcCtD
Histamine Phosphate—Erythema—Epirubicin—uterine cancer	0.000172	0.000872	CcSEcCtD
Histamine Phosphate—Malnutrition—Epirubicin—uterine cancer	0.000172	0.000872	CcSEcCtD
Histamine Phosphate—Diarrhoea—Etoposide—uterine cancer	0.000171	0.000868	CcSEcCtD
Histamine Phosphate—Flushing—Doxorubicin—uterine cancer	0.00017	0.00086	CcSEcCtD
Histamine Phosphate—Cardiac disorder—Doxorubicin—uterine cancer	0.00017	0.00086	CcSEcCtD
Histamine Phosphate—Flatulence—Epirubicin—uterine cancer	0.000169	0.000859	CcSEcCtD
Histamine Phosphate—Dysgeusia—Epirubicin—uterine cancer	0.000168	0.000854	CcSEcCtD
Histamine Phosphate—Back pain—Epirubicin—uterine cancer	0.000166	0.000843	CcSEcCtD
Histamine Phosphate—Angiopathy—Doxorubicin—uterine cancer	0.000166	0.000841	CcSEcCtD
Histamine Phosphate—Dizziness—Etoposide—uterine cancer	0.000166	0.000839	CcSEcCtD
Histamine Phosphate—Muscle spasms—Epirubicin—uterine cancer	0.000165	0.000838	CcSEcCtD
Histamine Phosphate—Mediastinal disorder—Doxorubicin—uterine cancer	0.000165	0.000835	CcSEcCtD
Histamine Phosphate—Chills—Doxorubicin—uterine cancer	0.000164	0.000831	CcSEcCtD
Histamine Phosphate—Arrhythmia—Doxorubicin—uterine cancer	0.000163	0.000828	CcSEcCtD
Histamine Phosphate—Mental disorder—Doxorubicin—uterine cancer	0.00016	0.000812	CcSEcCtD
Histamine Phosphate—Ill-defined disorder—Epirubicin—uterine cancer	0.00016	0.000809	CcSEcCtD
Histamine Phosphate—Vomiting—Etoposide—uterine cancer	0.000159	0.000807	CcSEcCtD
Histamine Phosphate—Malnutrition—Doxorubicin—uterine cancer	0.000159	0.000806	CcSEcCtD
Histamine Phosphate—Erythema—Doxorubicin—uterine cancer	0.000159	0.000806	CcSEcCtD
Histamine Phosphate—Anaemia—Epirubicin—uterine cancer	0.000159	0.000806	CcSEcCtD
Histamine Phosphate—Rash—Etoposide—uterine cancer	0.000158	0.0008	CcSEcCtD
Histamine Phosphate—Dermatitis—Etoposide—uterine cancer	0.000158	0.000799	CcSEcCtD
Histamine Phosphate—Headache—Etoposide—uterine cancer	0.000157	0.000795	CcSEcCtD
Histamine Phosphate—Flatulence—Doxorubicin—uterine cancer	0.000157	0.000795	CcSEcCtD
Histamine Phosphate—Dysgeusia—Doxorubicin—uterine cancer	0.000156	0.00079	CcSEcCtD
Histamine Phosphate—Malaise—Epirubicin—uterine cancer	0.000155	0.000786	CcSEcCtD
Histamine Phosphate—Vertigo—Epirubicin—uterine cancer	0.000155	0.000783	CcSEcCtD
Histamine Phosphate—Leukopenia—Epirubicin—uterine cancer	0.000154	0.00078	CcSEcCtD
Histamine Phosphate—Back pain—Doxorubicin—uterine cancer	0.000154	0.00078	CcSEcCtD
Histamine Phosphate—Muscle spasms—Doxorubicin—uterine cancer	0.000153	0.000775	CcSEcCtD
Histamine Phosphate—Palpitations—Epirubicin—uterine cancer	0.000152	0.00077	CcSEcCtD
Histamine Phosphate—Cough—Epirubicin—uterine cancer	0.00015	0.000761	CcSEcCtD
Histamine Phosphate—Convulsion—Epirubicin—uterine cancer	0.000149	0.000755	CcSEcCtD
Histamine Phosphate—Nausea—Etoposide—uterine cancer	0.000149	0.000754	CcSEcCtD
Histamine Phosphate—Hypertension—Epirubicin—uterine cancer	0.000148	0.000752	CcSEcCtD
Histamine Phosphate—Ill-defined disorder—Doxorubicin—uterine cancer	0.000148	0.000748	CcSEcCtD
Histamine Phosphate—Anaemia—Doxorubicin—uterine cancer	0.000147	0.000745	CcSEcCtD
Histamine Phosphate—Chest pain—Epirubicin—uterine cancer	0.000146	0.000742	CcSEcCtD
Histamine Phosphate—Myalgia—Epirubicin—uterine cancer	0.000146	0.000742	CcSEcCtD
Histamine Phosphate—Arthralgia—Epirubicin—uterine cancer	0.000146	0.000742	CcSEcCtD
Histamine Phosphate—Anxiety—Epirubicin—uterine cancer	0.000146	0.000739	CcSEcCtD
Histamine Phosphate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000145	0.000737	CcSEcCtD
Histamine Phosphate—Discomfort—Epirubicin—uterine cancer	0.000145	0.000733	CcSEcCtD
Histamine Phosphate—Malaise—Doxorubicin—uterine cancer	0.000144	0.000727	CcSEcCtD
Histamine Phosphate—Dry mouth—Epirubicin—uterine cancer	0.000143	0.000726	CcSEcCtD
Histamine Phosphate—Vertigo—Doxorubicin—uterine cancer	0.000143	0.000725	CcSEcCtD
Histamine Phosphate—Leukopenia—Doxorubicin—uterine cancer	0.000142	0.000722	CcSEcCtD
Histamine Phosphate—Confusional state—Epirubicin—uterine cancer	0.000142	0.000717	CcSEcCtD
Histamine Phosphate—Palpitations—Doxorubicin—uterine cancer	0.000141	0.000713	CcSEcCtD
Histamine Phosphate—Anaphylactic shock—Epirubicin—uterine cancer	0.00014	0.000711	CcSEcCtD
Histamine Phosphate—Infection—Epirubicin—uterine cancer	0.000139	0.000707	CcSEcCtD
Histamine Phosphate—Cough—Doxorubicin—uterine cancer	0.000139	0.000704	CcSEcCtD
Histamine Phosphate—Shock—Epirubicin—uterine cancer	0.000138	0.0007	CcSEcCtD
Histamine Phosphate—Convulsion—Doxorubicin—uterine cancer	0.000138	0.000699	CcSEcCtD
Histamine Phosphate—Nervous system disorder—Epirubicin—uterine cancer	0.000138	0.000698	CcSEcCtD
Histamine Phosphate—Thrombocytopenia—Epirubicin—uterine cancer	0.000137	0.000696	CcSEcCtD
Histamine Phosphate—Hypertension—Doxorubicin—uterine cancer	0.000137	0.000696	CcSEcCtD
Histamine Phosphate—Tachycardia—Epirubicin—uterine cancer	0.000137	0.000694	CcSEcCtD
Histamine Phosphate—Skin disorder—Epirubicin—uterine cancer	0.000136	0.000691	CcSEcCtD
Histamine Phosphate—Hyperhidrosis—Epirubicin—uterine cancer	0.000136	0.000688	CcSEcCtD
Histamine Phosphate—Arthralgia—Doxorubicin—uterine cancer	0.000135	0.000687	CcSEcCtD
Histamine Phosphate—Myalgia—Doxorubicin—uterine cancer	0.000135	0.000687	CcSEcCtD
Histamine Phosphate—Chest pain—Doxorubicin—uterine cancer	0.000135	0.000687	CcSEcCtD
Histamine Phosphate—Anxiety—Doxorubicin—uterine cancer	0.000135	0.000684	CcSEcCtD
Histamine Phosphate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000135	0.000682	CcSEcCtD
Histamine Phosphate—Discomfort—Doxorubicin—uterine cancer	0.000134	0.000678	CcSEcCtD
Histamine Phosphate—Anorexia—Epirubicin—uterine cancer	0.000134	0.000678	CcSEcCtD
Histamine Phosphate—Dry mouth—Doxorubicin—uterine cancer	0.000133	0.000671	CcSEcCtD
Histamine Phosphate—Hypotension—Epirubicin—uterine cancer	0.000131	0.000665	CcSEcCtD
Histamine Phosphate—Confusional state—Doxorubicin—uterine cancer	0.000131	0.000664	CcSEcCtD
Histamine Phosphate—Anaphylactic shock—Doxorubicin—uterine cancer	0.00013	0.000658	CcSEcCtD
Histamine Phosphate—Infection—Doxorubicin—uterine cancer	0.000129	0.000654	CcSEcCtD
Histamine Phosphate—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000128	0.000648	CcSEcCtD
Histamine Phosphate—Shock—Doxorubicin—uterine cancer	0.000128	0.000648	CcSEcCtD
Histamine Phosphate—Nervous system disorder—Doxorubicin—uterine cancer	0.000127	0.000645	CcSEcCtD
Histamine Phosphate—Thrombocytopenia—Doxorubicin—uterine cancer	0.000127	0.000644	CcSEcCtD
Histamine Phosphate—Insomnia—Epirubicin—uterine cancer	0.000127	0.000643	CcSEcCtD
Histamine Phosphate—Tachycardia—Doxorubicin—uterine cancer	0.000127	0.000642	CcSEcCtD
Histamine Phosphate—Skin disorder—Doxorubicin—uterine cancer	0.000126	0.000639	CcSEcCtD
Histamine Phosphate—Paraesthesia—Epirubicin—uterine cancer	0.000126	0.000639	CcSEcCtD
Histamine Phosphate—Hyperhidrosis—Doxorubicin—uterine cancer	0.000126	0.000636	CcSEcCtD
Histamine Phosphate—Dyspnoea—Epirubicin—uterine cancer	0.000125	0.000634	CcSEcCtD
Histamine Phosphate—Anorexia—Doxorubicin—uterine cancer	0.000124	0.000627	CcSEcCtD
Histamine Phosphate—Dyspepsia—Epirubicin—uterine cancer	0.000124	0.000626	CcSEcCtD
Histamine Phosphate—Decreased appetite—Epirubicin—uterine cancer	0.000122	0.000618	CcSEcCtD
Histamine Phosphate—Hypotension—Doxorubicin—uterine cancer	0.000121	0.000615	CcSEcCtD
Histamine Phosphate—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000121	0.000614	CcSEcCtD
Histamine Phosphate—Fatigue—Epirubicin—uterine cancer	0.000121	0.000613	CcSEcCtD
Histamine Phosphate—Constipation—Epirubicin—uterine cancer	0.00012	0.000608	CcSEcCtD
Histamine Phosphate—Pain—Epirubicin—uterine cancer	0.00012	0.000608	CcSEcCtD
Histamine Phosphate—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000118	0.0006	CcSEcCtD
Histamine Phosphate—Insomnia—Doxorubicin—uterine cancer	0.000117	0.000595	CcSEcCtD
Histamine Phosphate—Paraesthesia—Doxorubicin—uterine cancer	0.000117	0.000591	CcSEcCtD
Histamine Phosphate—Dyspnoea—Doxorubicin—uterine cancer	0.000116	0.000587	CcSEcCtD
Histamine Phosphate—Feeling abnormal—Epirubicin—uterine cancer	0.000116	0.000586	CcSEcCtD
Histamine Phosphate—Gastrointestinal pain—Epirubicin—uterine cancer	0.000115	0.000582	CcSEcCtD
Histamine Phosphate—Dyspepsia—Doxorubicin—uterine cancer	0.000114	0.000579	CcSEcCtD
Histamine Phosphate—Decreased appetite—Doxorubicin—uterine cancer	0.000113	0.000572	CcSEcCtD
Histamine Phosphate—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000112	0.000568	CcSEcCtD
Histamine Phosphate—Fatigue—Doxorubicin—uterine cancer	0.000112	0.000567	CcSEcCtD
Histamine Phosphate—Urticaria—Epirubicin—uterine cancer	0.000112	0.000565	CcSEcCtD
Histamine Phosphate—Pain—Doxorubicin—uterine cancer	0.000111	0.000563	CcSEcCtD
Histamine Phosphate—Constipation—Doxorubicin—uterine cancer	0.000111	0.000563	CcSEcCtD
Histamine Phosphate—Abdominal pain—Epirubicin—uterine cancer	0.000111	0.000562	CcSEcCtD
Histamine Phosphate—Body temperature increased—Epirubicin—uterine cancer	0.000111	0.000562	CcSEcCtD
Histamine Phosphate—Feeling abnormal—Doxorubicin—uterine cancer	0.000107	0.000542	CcSEcCtD
Histamine Phosphate—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000106	0.000538	CcSEcCtD
Histamine Phosphate—Hypersensitivity—Epirubicin—uterine cancer	0.000103	0.000524	CcSEcCtD
Histamine Phosphate—Urticaria—Doxorubicin—uterine cancer	0.000103	0.000523	CcSEcCtD
Histamine Phosphate—Abdominal pain—Doxorubicin—uterine cancer	0.000103	0.00052	CcSEcCtD
Histamine Phosphate—Body temperature increased—Doxorubicin—uterine cancer	0.000103	0.00052	CcSEcCtD
Histamine Phosphate—Asthenia—Epirubicin—uterine cancer	0.000101	0.00051	CcSEcCtD
Histamine Phosphate—Pruritus—Epirubicin—uterine cancer	9.93e-05	0.000503	CcSEcCtD
Histamine Phosphate—Diarrhoea—Epirubicin—uterine cancer	9.6e-05	0.000487	CcSEcCtD
Histamine Phosphate—Hypersensitivity—Doxorubicin—uterine cancer	9.57e-05	0.000485	CcSEcCtD
Histamine Phosphate—Asthenia—Doxorubicin—uterine cancer	9.32e-05	0.000472	CcSEcCtD
Histamine Phosphate—Dizziness—Epirubicin—uterine cancer	9.28e-05	0.00047	CcSEcCtD
Histamine Phosphate—Pruritus—Doxorubicin—uterine cancer	9.19e-05	0.000466	CcSEcCtD
Histamine Phosphate—Vomiting—Epirubicin—uterine cancer	8.93e-05	0.000452	CcSEcCtD
Histamine Phosphate—Diarrhoea—Doxorubicin—uterine cancer	8.89e-05	0.00045	CcSEcCtD
Histamine Phosphate—Rash—Epirubicin—uterine cancer	8.85e-05	0.000449	CcSEcCtD
Histamine Phosphate—Dermatitis—Epirubicin—uterine cancer	8.84e-05	0.000448	CcSEcCtD
Histamine Phosphate—Headache—Epirubicin—uterine cancer	8.79e-05	0.000446	CcSEcCtD
Histamine Phosphate—Dizziness—Doxorubicin—uterine cancer	8.59e-05	0.000435	CcSEcCtD
Histamine Phosphate—Nausea—Epirubicin—uterine cancer	8.34e-05	0.000423	CcSEcCtD
Histamine Phosphate—Vomiting—Doxorubicin—uterine cancer	8.26e-05	0.000418	CcSEcCtD
Histamine Phosphate—Rash—Doxorubicin—uterine cancer	8.19e-05	0.000415	CcSEcCtD
Histamine Phosphate—Dermatitis—Doxorubicin—uterine cancer	8.18e-05	0.000415	CcSEcCtD
Histamine Phosphate—Headache—Doxorubicin—uterine cancer	8.14e-05	0.000412	CcSEcCtD
Histamine Phosphate—Nausea—Doxorubicin—uterine cancer	7.71e-05	0.000391	CcSEcCtD
